Voyager Therapeutics (VYGR)
(Delayed Data from NSDQ)
$8.67 USD
-0.10 (-1.14%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $8.68 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Voyager Therapeutics, Inc. [VYGR]
Reports for Purchase
Showing records 141 - 145 ( 145 total )
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Q1 EPS; Key Coverage Data Around the Corner, Reiterate OUTPERFORM.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Lead Programs Highlighted; Two New Programs Announced
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Q4 Financials; On Track for Key Updates and POC in Advanced Parkinson''s Disease in 2016; Reiterate OUTPERFORM and PT of $36
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Initiating Coverage with an OUTPERFORM and $36 Price Target; Journeying into the CNS with AAV Gene Therapy
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D